Catalyst Wire Dossier Catalyst Wire Dossier

Eloctate

efmoroctocog alfa
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Eloctate, covering 2025-01-16 to 2025-01-16. Get the full timeline:

Most recent: Clinical Trial Update: An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog Alfa [Phase 4]

See pricing